IRIX: Iridex Corp Company Profile & Statistics

About

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

Info & Links

CEO

David I. Bruce

Headquarters

1212 Terra Bella Avenue
Mountain View, CA 94043, UNITED STATES

Auditor

BPM LLP

Share holders

Employees

111

Iridex Corp Statistics

Valuation Measures

Market Capitalization²

15.87M

Enterprise Value

14.77M

Enterprise Value/EBITDA(ttm)

-1.49

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.52

Price to Book(mrq)

9.57

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

39.97%

Operating Margin(ttm)

-22.79%

Profit Margin(ttm)

-18.48%

Return on Equity(ttm)

-192.95%

Return on Invested Capital(ttm)

-190.91%

Return on Assets(ttm)

-33.97%

Income Statement

Revenue(ttm)

48.43M

Revenue Per Share(ttm)

2.91

Gross Profit(ttm)

18.80M

EBITDA(ttm)³

-9.92M

Net Income Available to Common(ttm)

-11.04M

Diluted EPS(ttm)

-0.67

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

-69.74%

S&P 500 52-Week Change

4.84%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

16.64M

Dividend Yield

0.00%

Float⁴

15.42M

% Held by Insiders

7.30%

% Held by Institutions

20.10%

Balance Sheet

Total Cash(mrq)

3.86M

Total Cash Per Share(mrq)

0.23

Total Debt(mrq)

2.76M

Total Debt/Equity(mrq)

130.57%

Current Ratio(mrq)

1.42%

Quick Ratio(mrq)

0.85%

Book Value Per Share(mrq)

0.13

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.44

Free Cash Flow(ytd)

-7.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IRIX

Iridex Corp

Iridex Corp Profile